首页> 外国专利> Isoxazolicos resorcinol Derivatives, Pharmaceutical compositions containing Intermediates, Synthesis process, The Synthesis and use of same in Neurodegenerative Disorders and as antitumor agents.

Isoxazolicos resorcinol Derivatives, Pharmaceutical compositions containing Intermediates, Synthesis process, The Synthesis and use of same in Neurodegenerative Disorders and as antitumor agents.

机译:异恶唑间苯二酚衍生物,含有中间体的药物组合物,合成方法,其在神经退行性疾病中的合成和用途以及作为抗肿瘤剂。

摘要

This request is directed at alternative m-phenol derivatives that inhibit Hsp90 heat shock protein activity. Therefore, the compound in the application can be used for the treatment of diffuse diseases such as cancer and neurodegenerative diseases. The application also provides the preparation process of these compounds, the pharmaceutical ingredients containing these compounds, the method for treating diseases and the pharmaceutical ingredients containing these compounds. Requirement 1: the properties of a compound, because it has formula (1), where Z is - CH = ch,- (CH2) p, where p is 0, 1, 2 or 3, NH, O, S, S = O, SO2 or C = O; R is an optionally substituted linear or branched C1-7 alkyl, C2-7 alkenyl or C2-7 alkynyl, C3-7 cycloalkyl, C4-7 cycloalkenyl, phenyl, naphthyl, 5- or 6-membered heteroaryl, saturated or partially heterocyclic ring saturated comprising one or more oxygen, sulfur or nitrogen atoms, or is a CONHR2, CH2NHR2, NHCOR2 or NHCONHR2 group where R2 is an optionally substituted linear or branched C1-7 alkyl, C2-7 alkenyl or C2-7 alkynyl group, C3-7 cycloalkyl, C4-7 cycloalkenyl, phenyl, naphthyl, 5- or 6-membered heteroaryl,A saturated or partially saturated heterocycle consisting of one or more oxygen, sulfur, or nitrogen atoms; X is ch, N, NH, or O; w e is an independent ch, N, NH, or s; R1 is a group of NH2, nhconhr2, nhcor2, nso2r2, or conhr2, R2 is defined above; a ring containing x, Y and W, as defined above, are a heteromorphic group, or a medically acceptable salt.
机译:该要求针对抑制Hsp90热激蛋白活性的替代间苯酚衍生物。因此,本申请中的化合物可用于治疗弥漫性疾病,例如癌症和神经退行性疾病。本申请还提供了这些化合物的制备方法,包含这些化合物的药物成分,治疗疾病的方法以及包含这些化合物的药物成分。要求1:化合物的性质,因为它具有式(1),其中Z为-CH = ch,-(CH2)p,其中p为0、1、2或3,NH,O,S,> S = O,> SO2或> C = O; R是任选取代的直链或支链的C 1-7烷基,C 2-7烯基或C 2-7炔基,C 3-7环烷基,C 4-7环烯基,苯基,萘基,5-或6-元杂芳基,饱和或部分杂环的环饱和的,包含一个或多个氧,硫或氮原子,或为CONHR2,CH2NHR2,NHCOR2或NHCONHR2基团,其中R2为可选取代的直链或支链C1-7烷基,C2-7烯基或C2-7炔基,C3- 7环烷基,C 4-7环烯基,苯基,萘基,5-或6-元杂芳基,由一个或多个氧,硫或氮原子组成的饱和或部分饱和的杂环; X是ch,N,NH或O; w e是独立的ch,N,NH或s; R1是NH2,nhconhr2,nhcor2,nso2r2或conhr2的基团,R2如上所定义;如上定义的含有x,y和w的环是杂晶基团或医学上可接受的盐。

著录项

  • 公开/公告号AR076645A1

    专利类型

  • 公开/公告日2011-06-29

    原文格式PDF

  • 申请/专利权人 NERVIANO MEDICAL SCIENCES S.R.L.;

    申请/专利号AR2010P101286

  • 发明设计人

    申请日2010-04-19

  • 分类号C07D261/14;C07D261/18;C07D413/12;C07D413/14;C07D453/02;A61K31/42;A61P35/00;A61P25/28;

  • 国家 AR

  • 入库时间 2022-08-21 18:07:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号